Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s footer now includes a 2023 U.S. NIH Grant/Contract acknowledgment, and the revision tag has been updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T00:35:33.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 on the study page, indicating a minor metadata update. There are no visible changes to the trial information presented.
    Difference
    0.0%
    Check dated 2026-08-08T22:30:58.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, reflecting a new build of the page.
    Difference
    0.0%
    Check dated 2026-07-25T12:57:03.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The revision line updated from v3.6.2 to v3.6.3, reflecting a minor version update of the site. This change represents a backend/branding update and does not modify the study details or presented information.
    Difference
    0.0%
    Check dated 2026-07-03T23:56:43.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The revision label on the page has been updated to v3.6.2, indicating a minor maintenance update to the page's versioning information.
    Difference
    0.0%
    Check dated 2026-06-26T23:29:23.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    New participant-focused navigation links were added (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was standardized. The page version was updated from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T14:28:57.000Z thumbnail image

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.